Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Stock Price, Quote & AI Analysis
Live MDGL stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Madrigal Pharmaceuticals, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Madrigal Pharmaceuticals, Inc. Common Stock (MDGL), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Madrigal Pharmaceuticals, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Madrigal Pharmaceuticals, Inc. Common Stock Overview
Company information
Company Overview
Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Madrigal Pharmaceuticals, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...